The Patient Perspective
Jay Gee, now aged 46 years, had known something was wrong for decades. Since they were a teenager, Gee was mostly bedbound with fatigue, nausea, incontinence, numbness, difficulty walking, and vision problems.
But no health care professionals (HCPs) would listen to Gee, who identifies as nonbinary, including the physicians in the north of England who said their symptoms were “all in their head” and the psychologist who tried to section them. Gee received a diagnosis of chronic fatigue syndrome and was prescribed antidepressants and a course of cognitive behavioral therapy.
Finally, Gee had enough. After researching online and acquiring a new credit card, they paid to see a neurologist privately, who took a detailed medical history and ordered tests, including an MRI. The neurologist confirmed what Gee had long suspected: They had multiple sclerosis (MS) with significant cerebral atrophy. They have been treated with alemtuzumab.
Gee’s experience has left them traumatized, scarred, and angry. “It hurts every second of every day to think how much of my brain health professionals stole from me,” they say.
Gee now knows they were a victim of medical gaslighting, a term used for when HCPs downplay, dismiss, or ignore a patient’s symptoms or wrongly blame their concerns on psychological factors.1 At best, it can cause a person to leave their physician’s office feeling frustrated, confused, or full of self-doubt.2 At worst, it can cause a delay in a patient receiving the correct diagnosis and treatment, which can lead to irreversible damage.3,4 We believe gaslighting disproportionately affects individuals with MS, and thus, it is key to address. In this article, we offer ways for patients to avoid it because the consequences can be so severe.
“Medical gaslighting happens quite often in MS,” Mitzi Joi Williams, MD, a neurologist with a practice in Smyrna, Georgia, says. “It most commonly occurs during the process of diagnosis but can also occur when symptoms are worsening, and there is a delay in escalating a patient to more effective treatments.”
Origins
The term gaslighting comes from the 1938 play-turned-film Gaslight, which tells of a husband’s manipulative attempts to drive his wife insane so he can commit her to a mental institution and steal her inheritance. During the 1960s, the word began to appear in psychological literature5 to describe emotional abuse in intimate relationships.
Recently, the phenomenon of gaslighting has been attracting attention in the general public. The US dictionary Merriam-Webster chose it as its word of the year in 2022.6 It has crossed over to medicine in the past decade to refer to a physician trivializing or downplaying a patient’s health concerns.7 HCPs may be unaware of the term medical gaslighting, although some may have come across it in recent articles, such as one published in the British Medical Journal (BMJ).8
We suspect this health care bias has long occurred, but it has only recently become a focus of attention because individuals are using social media to call it out. For example, those with MS who believe their symptoms have been inappropriately dismissed have used hashtags such as #medicalgaslighting and #PatientsAreNotFaking to post their experiences on platforms such as Instagram and TikTok.9 In addition, in recent years, celebrities have also been going public with their MS stories, including their encounters with medical gaslighting.10
One such celebrity is Selma Blair, who writes in her book Mean Baby that she endured MS symptoms for decades but was never taken seriously by physicians “who blamed hormones, depression, anxiety, exhaustion, malnutrition, [and] my ‘neurasthenic’ nature. One doctor went so far as to tell me I might feel better if I had a boyfriend.”
Medical gaslighting can happen to anyone, but it overwhelmingly affects women,11 particularly women from racial and ethnic minority groups.12 Women may receive a misdiagnosis more often because research into diseases that affect women has consistently been marginalized and underfunded.13
We also know women and racial and ethnic minority individuals often wait longer to receive a diagnosis of heart disease and cancer and are treated less aggressively for chronic pain14 and traumatic brain injury.15 In addition, research shows women from racial and ethnic minority groups, women with disabilities, older women, or women with lower socioeconomic status also receive lower-quality health care, according to Melinda Wenner Moyer in her recent piece in The New York Times.16
Double Whammy
That brings us to MS. We cannot point to any specific study findings or statistics, but we believe medical gaslighting is a pervasive problem in MS for 2 reasons. MS is a disease that, as is common with many autoimmune conditions, largely affects women,17 who have been victims of medical gaslighting historically. Add to this that MS is a notoriously tricky disease to diagnose and manage.18 Presently, there is no single biomarker to confirm an individual has MS, so it often takes dedicated medical sleuthing on the part of a neurologist to determine a diagnosis.